...
首页> 外文期刊>British Journal of Cancer >MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways
【24h】

MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways

机译:口腔鳞状细胞癌的MicroRNA表达特征: microRNA-26a / b 在调节新型癌症途径中的功能作用

获取原文

摘要

Background: MicroRNAs (miRNAs) have been shown to play major roles in carcinogenesis in a variety of cancers. The aim of this study was to determine the miRNA expression signature of oral squamous cell carcinoma (OSCC) and to investigate the functional roles of miR-26a and miR-26b in OSCC cells. Methods: An OSCC miRNA signature was constructed by PCR-based array methods. Functional studies of differentially expressed miRNAs were performed to investigate cell proliferation, migration, and invasion in OSCC cells. In silico database and genome-wide gene expression analyses were performed to identify molecular targets and pathways mediated by miR-26a/b . Results: miR-26a and miR-26b were significantly downregulated in OSCC. Restoration of both miR-26a and miR-26b in cancer cell lines revealed that these miRNAs significantly inhibited cancer cell migration and invasion. Our data demonstrated that the novel transmembrane TMEM184B gene was a direct target of miR-26a/b regulation. Silencing of TMEM184B inhibited cancer cell migration and invasion, and regulated the actin cytoskeleton-pathway related genes. Conclusions: Loss of tumour-suppressive miR-26a/b enhanced cancer cell migration and invasion in OSCC through direct regulation of TMEM184B . Our data describing pathways regulated by tumour-suppressive miR-26a/b provide new insights into the potential mechanisms of OSCC oncogenesis and metastasis.
机译:背景:MicroRNA(miRNA)已显示在多种癌症的致癌作用中起主要作用。这项研究的目的是确定口腔鳞状细胞癌(OSCC)的miRNA表达特征,并研究miR-26a和miR-26b在OSCC细胞中的功能。方法:通过基于PCR的阵列方法构建OSCC miRNA签名。进行了差异表达的miRNA的功能研究,以研究OSCC细胞中的细胞增殖,迁移和侵袭。在计算机数据库和全基因组范围内进行基因表达分析,以鉴定由miR-26a / b介导的分子靶标和途径。结果:OSR中的miR-26a和miR-26b明显下调。癌细胞系中miR-26a和miR-26b的恢复显示,这些miRNA显着抑制了癌细胞的迁移和侵袭。我们的数据表明,新型跨膜TMEM184B基因是miR-26a / b调控的直接靶标。沉默的TMEM184B抑制癌细胞迁移和侵袭,并调节肌动蛋白细胞骨架通路相关基因。结论:肿瘤抑制性miR-26a / b的丧失通过直接调控TMEM184B增强了OSCC中的癌细胞迁移和侵袭。我们的数据描述了由肿瘤抑制性miR-26a / b调控的通路,为OSCC肿瘤发生和转移的潜在机制提供了新见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号